The nine-day trial of Tina Burris v Johnson & Johnson ended with a defendant win after jurors decided the company had issued adequate warnings about the risks of Prolift.
Kila Baldwin, who has won in excess of $150 million for transvaginal mesh injured women, has broken from Philadelphia-based Kline Specter to form a new personal injury law firm.
Tina Burris, implanted with two transvaginal meshes made by Johnson & Johnson (Ethicon) will have her defective product day in a Toledo, Ohio courtroom beginning in July.
JNJ was facing $344 million in civil penalties after California accused it of making misleading statements that minimized the health risks of its pelvic mesh. This is the latest settlement with states
The trial over Ethicon's Abbrevo SUI mesh sling is finally set for May 24, 2022 after much courtroom wrangling between the implanting doctor and the company, owned by Johnson & Johnson.
How well were you represented in your personal injury case against mesh makers? Some plaintiffs allege, not very well.
This is the second lawsuit filed against law firms involved in pelvic mesh cases who warehoused thousands of cases, some expired, then run them through the settlement mill en masse.
The Mazie Slater law firm of Roseland, New Jersey has filed a class action that could retrieve $15 million in allegedly excess fees collected by plaintiffs' lawyers.
The pelvic mesh trial of Patricia Mesigian, conducted in Philadelphia, ended with an $80M jury award to the mesh-injured woman.
Attorney and law professor, Elizabeth Chamblee Burch advised on what you should ask if you need to hire an attorney, especially if you are part of a mass tort.
Trial was supposed to begin Monday morning, April 23, 2019, as Washington State sued Johnson & Johnson over failing to provide women a warning about the company's polypropylene pelvic mesh implants.
Neurological Injuries: Path More Certain. Sponsored Content. Dr. Greg Vigna, JD, talks about his continued focus on pelvic mesh injuries with a neurological component.
With so much money at stake, the accusations are flying among lawyers trying to divvy the hundreds of millions of dollars set aside as the common benefit fund to go to those who did the heavy lifting.
While more than $7 billion has gone to settle pelvic mesh cases, some law firms believe their contribution to trying the cases is being subverted and they are being cheated of what they are due.
This story was originally published in May 2018. It is addressed to the thousands of women who are waiting- for a settlement or a defective product trial.
In terms of pelvic mesh litigation, those women with a "Mesh in Place" that is, no revision, there is a way to stay in the pelvic mesh litigation.
Have you received a pelvic mesh settlement? Are you about to? Please understand there is a fee involved of 5% that must be contributed to a common benefit fund. But who is supposed to pay it?
The judge overseeing more than 100-thousand pelvic mesh product liability lawsuits addressed the lawyers involved in pelvic mesh litigation. He delivered good news, they can split $550M from a 5% fund
What happened with the Mesh Mess in 2018? Here are just some of the highlights of coverage in the U.S. in 2018 with many more stories reported glob…
It had to happen. The hundreds of millions of dollars resulting from the 5% common benefit fund, $500m? needs to be divided among law firms involved with mesh litigation. Can you say contentious?
It began in January 2012. Multidistrict litigation (MDL) was supposed to make getting to trial easier to eliminate the confusion on conflicted lower court rulings, but 6 years later, it's closing.
The story of polypropylene mesh and whether it was sourced from China from a substandard facility to make device implants is the subject of a profile on 60 Minutes.
Can you change your law firm if you are not happy with representation in your defective products case?
During the opening day of the Elizabeth Hrymoc v. Ethicon defective product trial, her lawyer said the Prolift mesh was a "stupid idea", and others agree.
Mesh Medical Device News Desk (MND) keeps tabs on the number of trials that have been heard so far in the pelvic mesh MDL and elsewhere.
The Lancet is one of the oldest medical journals in the world. Ed Holt writes for The Lancet about the FDA's decision to suspend the sales of POP mesh because of safety and efficacy concerns.
http://www.clinicaladvisor.com/obgyn-information-center/benefits-and-harms-of-transvagnial-mesh/article/476188/ http://www.massdevice.com/johnson-joh…
It doesn't seem like it was that long ago when the issue of polypropylene mesh used for surgery was known by a few people. Truth in Medicine was proba...
Pinnacle Pelvic Floor Repair kit After a two week trial, Boston Scientific won its first product liability trial over transvaginal mesh. The jurors r...
